The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia
Tristram A. Lett(Charité - Universitätsmedizin Berlin), Aristotle N. Voineskos(Centre for Addiction and Mental Health), Eva J. Brandl(Centre for Addiction and Mental Health), James L. Kennedy(Unknown), Jason P. Lerch, Herbert Y. Meltzer(Northwestern University), Tarek K. Rajji(Centre for Addiction and Mental Health), Vanessa F. Gonçalves(Centre for Addiction and Mental Health), Daniel Felsky(Centre for Addiction and Mental Health), Jeffrey A. Lieberman(Unknown), Arun K. Tiwari(Centre for Addiction and Mental Health), Zafiris J. Daskalakis(University of San Diego), M M Chakavarty(Centre for Addiction and Mental Health), Benoit H. Mulsant(University of Toronto)
Cited by 119
Related Papers
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial
|The Lancet|2018|1.3k
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
A multi-omic atlas of the human frontal cortex for aging and Alzheimer’s disease research
|Scientific Data|2018|685
Meta-analysis and imputation refines the association of 15q25 with smoking quantity
|Nature Genetics|2010|618